In the BioHarmony Drug Report Database
Luliconazole
Luzu (luliconazole) is a small molecule pharmaceutical. Luliconazole was first approved as Luzu on 2013-11-14. It is used to treat mycoses and tinea in the USA. Luzu’s patents are valid until 2034-04-28 (FDA).
Trade Name
|
Luzu |
|---|---|
Common Name
|
luliconazole |
ChEMBL ID
|
CHEMBL2105689 |
Indication
|
mycoses, tinea |
Drug Class
|
Systemic antifungals (miconazole type) |
Image (chem structure or protein)